These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 12490493)

  • 1. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.
    Numata K; Morimoto M; Ogura T; Sugimori K; Takebayashi S; Okada M; Tanaka K
    J Ultrasound Med; 2008 Mar; 27(3):395-406. PubMed ID: 18314518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma.
    Numata K; Tanaka K; Kiba T; Saito S; Isozaki T; Hara K; Morimoto M; Sekihara H; Yonezawa H; Kubota T
    AJR Am J Roentgenol; 2001 May; 176(5):1199-205. PubMed ID: 11312181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonresectable hepatocellular carcinoma: improved percutaneous ethanol injection therapy guided by CO(2)-enhanced sonography.
    Numata K; Tanaka K; Kiba T; Matsumoto S; Iwase S; Hara K; Kirikoshi H; Morita K; Saito S; Sekihara H
    AJR Am J Roentgenol; 2001 Oct; 177(4):789-98. PubMed ID: 11566674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
    AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma.
    Pompili M; Riccardi L; Covino M; Barbaro B; Di Stasi C; Orefice R; Gasbarrini G; Rapaccini GL
    Liver Int; 2005 Oct; 25(5):954-61. PubMed ID: 16162152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography.
    Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Shiozaki H
    AJR Am J Roentgenol; 2004 Jul; 183(1):153-6. PubMed ID: 15208130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
    Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
    AJR Am J Roentgenol; 2001 Mar; 176(3):661-6. PubMed ID: 11222201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
    Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
    J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Lee WJ; Kim SH; Kim YH; Kim SH; Lim JH
    J Ultrasound Med; 2003 Nov; 22(11):1163-72. PubMed ID: 14620886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy.
    Koito K; Namieno T; Ichimura T; Hirokawa N; Syonai T; Hareyama M; Katsuramaki T; Hirata K; Nishi M
    AJR Am J Roentgenol; 2000 Feb; 174(2):337-41. PubMed ID: 10658701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US.
    Bartolozzi C; Lencioni R; Ricci P; Paolicchi A; Rossi P; Passariello R
    Radiology; 1998 Nov; 209(2):387-93. PubMed ID: 9807563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent.
    Maruyama H; Kobayashi S; Yoshizumi H; Okugawa H; Akiike T; Yukisawa S; Fukuda H; Matsutani S; Ebara M; Saisho H
    Clin Radiol; 2007 Jul; 62(7):668-75. PubMed ID: 17556036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging.
    Youk JH; Lee JM; Kim CS
    J Ultrasound Med; 2003 Sep; 22(9):911-20. PubMed ID: 14510262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma: therapeutic experience with percutaneous ethanol injection under real-time contrast-enhanced color Doppler sonography with the contrast agent Levovist.
    Shirato K; Morimoto M; Tomita N; Kokawa A; Sugimori K; Saito T; Numata K; Sekihara H; Tanaka K
    J Ultrasound Med; 2002 Sep; 21(9):1015-22. PubMed ID: 12216749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.